In any case, based on these results, we found that NOTCH3 is abnormally highly expressed in gastrointestinal tumors (COAD, LIHC, PAAD, STAD), breast cancer and lung cancer, and increased NOTCH3 expression was associated with poor prognosis. Here, NOTCH3 is linked to lung cancer.